Success Metrics

Clinical Success Rate
72.0%

Based on 18 completed trials

Completion Rate
72%(18/25)
Active Trials
19(25%)
Results Posted
50%(9 trials)
Terminated
7(9%)

Phase Distribution

Ph not_applicable
42
56%
Ph phase_4
4
5%
Ph phase_2
6
8%
Ph phase_1
2
3%
Ph phase_3
2
3%

Phase Distribution

2

Early Stage

6

Mid Stage

6

Late Stage

Phase Distribution56 total trials
Phase 1Safety & dosage
2(3.6%)
Phase 2Efficacy & side effects
6(10.7%)
Phase 3Large-scale testing
2(3.6%)
Phase 4Post-market surveillance
4(7.1%)
N/ANon-phased studies
42(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.1%

18 of 29 finished

Non-Completion Rate

37.9%

11 ended early

Currently Active

19

trials recruiting

Total Trials

75

all time

Status Distribution
Active(28)
Completed(18)
Terminated(11)
Other(18)

Detailed Status

Completed18
unknown18
Recruiting14
Not yet recruiting7
Terminated7
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
75
Active
19
Success Rate
72.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (3.6%)
Phase 26 (10.7%)
Phase 32 (3.6%)
Phase 44 (7.1%)
N/A42 (75.0%)

Trials by Status

completed1824%
not_yet_recruiting79%
recruiting1419%
withdrawn45%
enrolling_by_invitation23%
unknown1824%
active_not_recruiting57%
terminated79%

Recent Activity

Clinical Trials (75)

Showing 20 of 75 trialsScroll for more
NCT07726056Not Applicable

Performance After Cardiac Ablation in Endurance Athletes for Atrial Fibrillation

Recruiting
NCT06689488

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates

Recruiting
NCT07145177Phase 1

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Recruiting
NCT07582419

Hybrid Deep Learning Integrating Multimodal CEUS and Enhanced MRI to Optimize Early-Stage HCC Treatment Decisions

Not Yet Recruiting
NCT06869122

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates - UK

Recruiting
NCT07521618Not Applicable

One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation

Not Yet Recruiting
NCT06503744Not Applicable

Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer

Recruiting
NCT07517640Phase 2

Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial

Not Yet Recruiting
NCT07503769Not Applicable

CHU Dual-Energy Ablation in Ventricular Arrhythmia

Enrolling By Invitation
NCT07497178Not Applicable

MRgFUS for Childhood Epilepsy

Not Yet Recruiting
NCT07487662Phase 2

TACE or Ablation Combined With Sintilimab and Ipilimumab N01 as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With Intermediate-High Recurrence Risk

Not Yet Recruiting
NCT05524077Not Applicable

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia

Active Not Recruiting
NCT05786625

Bronchoscopic Microwave Ablation of Lung Tissue

Active Not Recruiting
NCT07272356Not Applicable

Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function

Active Not Recruiting
NCT07092774

Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)

Active Not Recruiting
NCT01898221Phase 3

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Completed
NCT05643209Not Applicable

Brugada Syndrome Substrate Characterization and Ablation

Recruiting
NCT03844399

(3D) Ultrasound Imaging Liver and Kidney

Recruiting
NCT00839566Phase 4

PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)

Terminated
NCT05707637

Bipolar Radio-frequency Ablation After Standard Unipolar Approach - Prospective Registry.

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
75